ScholarLens Back to search
2012•The Journal of Medical Theory and PracticeRequires access

Clinical Efficacy Analysis of Irbesartan Combined with Benazepril in Treatment of Diabetic Nephropathy

Ji Run Xu

Open publisher page 0 citations

Abstract

Objective:To investigate the clinical efficacy of irbesartan combined with benazepril in treatment of diabetic nephropathy.Methods:72 cases of 2 type diabetic nephropathy were divided into two groups,treated with single benazepril or benazepril combined with irbesartan,the efficacy of the two groups were observed.Results:Both UAER,SBP and DBP in two groups were decreased,and compared with control group,UAER in treatment group decreased more significantly(P0.05).There were no obvious adverse reactions in two groups.Conclusion:Using irbesartan combined with benazepril in treatment of diabetic nephropathy could significantly reduce urinary protein,control blood pressure and improve the outcome.

About this research paper

What this paper is about

Objective:To investigate the clinical efficacy of irbesartan combined with benazepril in treatment of diabetic nephropathy.Methods:72 cases of 2 type diabetic nephropathy were divided into two groups,treated with single benazepril or benazepril combined with irbesartan,the efficacy of the two groups were observed.Results:Both UAER,SBP and DBP in two groups were decreased,and compared with control group,UAER in treatment group decreased more significantly(P0.05).There were no obvious adverse reactions in two groups.Conclusion:Using irbesartan combined with benazepril in treatment of diabetic nephropathy could significantly reduce urinary protein,control blood pressure and improve the outcome.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective:To investigate the clinical efficacy of irbesartan combined with benazepril in treatment of diabetic nephropathy.Methods:72 cases of 2 type diabetic nephropathy were divided into two groups,treated with single benazepril or benazepril combined with irbesartan,the efficacy of the two groups were observed.Results:Both UAER,SBP and DBP in two groups were decreased,and compared with control group,UAER in treatment group decreased more significantly(P0.05).There were no obvious adverse reactions in two groups.Conclusion:Using irbesartan combined with benazepril in treatment of diabetic nephropathy could significantly reduce urinary protein,control blood pressure and improve the outcome.

Key concepts: Benazepril, Irbesartan, Medicine, Diabetic nephropathy, Urology, Clinical efficacy, Blood pressure, Internal medicine

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
Clinical Efficacy Analysis of Irbesartan Combined with Benazepril in Treatment of Diabetic Nephropathy — Research Paper | ScholarLens